Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

"Accelerated ear-age": a new measure of chemotherapy-induced ototoxicity.

Fligor BJ, Krasker JD, Villaluna D, Krailo M, Frazier AL.

Pediatr Blood Cancer. 2012 Nov;59(5):947-9. doi: 10.1002/pbc.24169.

PMID:
22492682
2.

Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study.

Marina N, Chang KW, Malogolowkin M, London WB, Frazier AL, Womer RB, Rescorla F, Billmire DF, Davis MM, Perlman EJ, Giller R, Lauer SJ, Olson TA; Children's Oncology Group..

Cancer. 2005 Aug 15;104(4):841-7.

3.

Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.

Freilich RJ, Kraus DH, Budnick AS, Bayer LA, Finlay JL.

Med Pediatr Oncol. 1996 Feb;26(2):95-100.

PMID:
8531860
4.

[Ototoxicity of cisplatin in children with malignant diseases].

Hadjilaskari P, Fengler R, Hartmann R, Henze G.

Klin Padiatr. 1989 Jul-Aug;201(4):316-21. German.

PMID:
2779137
5.

Relationship between cisplatin administration and the development of ototoxicity.

Rademaker-Lakhai JM, Crul M, Zuur L, Baas P, Beijnen JH, Simis YJ, van Zandwijk N, Schellens JH.

J Clin Oncol. 2006 Feb 20;24(6):918-24.

PMID:
16484702
6.

Carboplatin-associated ototoxicity in children with retinoblastoma.

Qaddoumi I, Bass JK, Wu J, Billups CA, Wozniak AW, Merchant TE, Haik BG, Wilson MW, Rodriguez-Galindo C.

J Clin Oncol. 2012 Apr 1;30(10):1034-41. doi: 10.1200/JCO.2011.36.9744.

7.

Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.

Schmidt CM, Knief A, Lagosch AK, Deuster D, am Zehnhoff-Dinnesen A.

Ear Hear. 2008 Dec;29(6):830-7. doi: 10.1097/AUD.0b013e31818005a4.

PMID:
18772725
8.

Effect of VAB-6 combination chemotherapy on malignant germ cell tumours in childhood.

Hayashi Y, Ohi R, Konno T, Tsuchiya S, Muraosa Y, Yaoita S, Watanabe T.

Z Kinderchir. 1989 Aug;44(4):208-12.

PMID:
2477963
9.

Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.

Bertolini P, Lassalle M, Mercier G, Raquin MA, Izzi G, Corradini N, Hartmann O.

J Pediatr Hematol Oncol. 2004 Oct;26(10):649-55.

PMID:
15454836
10.
11.

Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.

Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, Rogers PC, Colombani P, Rescorla F, Billmire DF, Vinocur CD, Hawkins EP, Davis MM, Perlman EJ, London WB, Castleberry RP; Pediatric Oncology Group 9049.; Children's Cancer Group 8882..

J Clin Oncol. 2004 Jul 1;22(13):2691-700.

PMID:
15226336
12.

Chemotherapy for the treatment of children and adolescents with malignant germ cell tumors.

Green DM.

J Clin Oncol. 2008 Jul 10;26(20):3297-8. doi: 10.1200/JCO.2008.16.5324. No abstract available.

PMID:
18612144
13.

[Preliminary evaluation of the toxicity and effectiveness of chemotherapy using the VAB-6 protocol in the treatment of non-seminoma of the testis].

Madej G, Gigier A, Siedlecki P, Pieńkowski T.

Nowotwory. 1987 Jan-Mar;37(1):44-9. Polish. No abstract available.

PMID:
2442730
14.

Ototoxicity of carboplatin: comparing animal and clinical models at the Hospital for Sick Children.

Macdonald MR, Harrison RV, Wake M, Bliss B, Macdonald RE.

J Otolaryngol. 1994 Jun;23(3):151-9.

PMID:
8064951
15.

Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older.

Feldman DR, Voss MH, Jacobsen EP, Jia X, Suarez JA, Turkula S, Sheinfeld J, Bosl GJ, Motzer RJ, Patil S.

Cancer. 2013 Jul 15;119(14):2574-81. doi: 10.1002/cncr.28025.

16.

Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.

Bass JK, Huang J, Onar-Thomas A, Chang KW, Bhagat SP, Chintagumpala M, Bartels U, Gururangan S, Hassall T, Heath JA, McCowage G, Cohn RJ, Fisher MJ, Robinson G, Broniscer A, Gajjar A, Gurney JG.

Pediatr Blood Cancer. 2014 Apr;61(4):601-5. doi: 10.1002/pbc.24830.

17.

Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours.

De Giorgi U, Rosti G, Slavin S, Yaniv I, Harousseau JL, Ladenstein R, Demirer T, Dini G; European Group for Blood and Marrow Transplantation Solid Tumours and Paediatric Disease Working Parties..

Br J Cancer. 2005 Aug 22;93(4):412-7.

18.

Chemotherapy immediately after surgery for patients with germ cell tumors.

Sella A, Logothetis CJ, Dexeus FH, Amato R.

Urology. 1990 Sep;36(3):264-6.

PMID:
2168105
19.

[BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].

Göbel U, Calaminus G, Teske C, Bamberg M, Bökkerink JP, Haas RJ, Holschneider AM, Janka-Schaub G, Jürgens H, Mittler U, et al.

Klin Padiatr. 1993 Jul-Aug;205(4):231-40. German.

PMID:
7690864
20.

Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients.

Wanderås EH, Fosså SD, Tretli S.

Eur J Cancer. 1997 Feb;33(2):253-62.

PMID:
9135497

Supplemental Content

Support Center